Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dawood

Showing results (151-160 of 192) with videos related to

Pageof 20
Sort By:
BMC Complementary Medicine and Therapies|July 15, 2024
Insights into bioactive constituents of onion (Allium cepa L.) waste: a comparative metabolomics study enhanced by chemometric toolsMariam M Elattar, Hala M Hammoda, Doaa A Ghareeb, et al.
Journal of the Egyptian Society of Parasitology|June 7, 2002
Detection of E. histolytica, G. lamblia and Cryptosporidium copro-antigens in stool samplesMohsen M Hassan, Hany Afify, Mohamed Abdel-Ghaffar, et al.
Clinical Laboratory|February 7, 2017
Level of Human Antibodies Targeting HCV E1/E2 Peptides and Spontaneous Clearance of HCV in Blood DonorsAshraf A Tabll, Eman A Salem, Yasmine S El-Abd, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|March 22, 2003
Prevalence and determinants of HIV-1 subtypes in Canada: enhancing routinely collected information through the Canadian HIV Strain and Drug Resistance Surveillance ProgramG C Jayaraman, T Gleeson, M L Rekart, et al.
Microbial Pathogenesis|February 20, 2021
Development of a gene signature for predicting cirrhosis risk score of chronic liver disease associated with HCV infection in EgyptiansReham M Dawood, Ghada M Salum, Mai Abd El-Meguid, et al.
BMC Infectious Diseases|November 7, 2019
A multiepitope peptide vaccine against HCV stimulates neutralizing humoral and persistent cellular responses in miceReham M Dawood, Rehab I Moustafa, Tawfeek H Abdelhafez, et al.
Viral Immunology|February 3, 2017
The Synergistic Effect of TNFα -308 G/A and TGFβ1 -509 C/T Polymorphisms on Hepatic Fibrosis Progression in Hepatitis C Virus Genotype 4 PatientsNoha G Bader El Din, Sally Farouk, Reem El-Shenawy, et al.
Journal, Genetic Engineering & Biotechnology|August 30, 2023
Recognition of 7 genes signature (Cirrhosis Risk Score) in the diagnosed non-responders to DAAs therapy by intra-PBMCs nested HCV RNA PCRAl-Shazly Gaber Mohamed Galal, Reham M Dawood, Mostafa K El Awady, et al.
Digestive Diseases and Sciences|April 29, 1999
Seroprevalence of Helicobacter pylori, incidence of gastric cancer, and peptic ulcer-associated hospitalizations in a Canadian Indian populationC N Bernstein, I McKeown, J M Embil, et al.
The British Journal of Radiology|January 1, 1994
Clinical diagnosis from digital displays: results and conclusions from the St Mary's evaluation projectR M Dawood, J O Craig, A Todd-Pokrapek, et al.
Pageof 20

Showing results (151-160 of 192) with videos related to

Sort By:
Pageof 20
BMC Complementary Medicine and Therapies|July 15, 2024
Insights into bioactive constituents of onion (Allium cepa L.) waste: a comparative metabolomics study enhanced by chemometric toolsMariam M Elattar, Hala M Hammoda, Doaa A Ghareeb, et al.
Journal of the Egyptian Society of Parasitology|June 7, 2002
Detection of E. histolytica, G. lamblia and Cryptosporidium copro-antigens in stool samplesMohsen M Hassan, Hany Afify, Mohamed Abdel-Ghaffar, et al.
Clinical Laboratory|February 7, 2017
Level of Human Antibodies Targeting HCV E1/E2 Peptides and Spontaneous Clearance of HCV in Blood DonorsAshraf A Tabll, Eman A Salem, Yasmine S El-Abd, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|March 22, 2003
Prevalence and determinants of HIV-1 subtypes in Canada: enhancing routinely collected information through the Canadian HIV Strain and Drug Resistance Surveillance ProgramG C Jayaraman, T Gleeson, M L Rekart, et al.
Microbial Pathogenesis|February 20, 2021
Development of a gene signature for predicting cirrhosis risk score of chronic liver disease associated with HCV infection in EgyptiansReham M Dawood, Ghada M Salum, Mai Abd El-Meguid, et al.
BMC Infectious Diseases|November 7, 2019
A multiepitope peptide vaccine against HCV stimulates neutralizing humoral and persistent cellular responses in miceReham M Dawood, Rehab I Moustafa, Tawfeek H Abdelhafez, et al.
Viral Immunology|February 3, 2017
The Synergistic Effect of TNFα -308 G/A and TGFβ1 -509 C/T Polymorphisms on Hepatic Fibrosis Progression in Hepatitis C Virus Genotype 4 PatientsNoha G Bader El Din, Sally Farouk, Reem El-Shenawy, et al.
Journal, Genetic Engineering & Biotechnology|August 30, 2023
Recognition of 7 genes signature (Cirrhosis Risk Score) in the diagnosed non-responders to DAAs therapy by intra-PBMCs nested HCV RNA PCRAl-Shazly Gaber Mohamed Galal, Reham M Dawood, Mostafa K El Awady, et al.
Digestive Diseases and Sciences|April 29, 1999
Seroprevalence of Helicobacter pylori, incidence of gastric cancer, and peptic ulcer-associated hospitalizations in a Canadian Indian populationC N Bernstein, I McKeown, J M Embil, et al.
The British Journal of Radiology|January 1, 1994
Clinical diagnosis from digital displays: results and conclusions from the St Mary's evaluation projectR M Dawood, J O Craig, A Todd-Pokrapek, et al.
Pageof 20